PCR-Based Testing Market by Product Type and Application- Global Industry Analysis & Forecast to 2027

Published On : January 2021 Pages : 173 Category: Pharma & Healthcare Report Code : HC0114698

PCR-Based Testing Market By Product Type (Analyzers/Instruments, Kits/Panels) and Application (Diagnosis and Treatment, Genetic Testing, Cancer, Evolutionary Biology, Others)- Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The PCR-Based Testing Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.PCR tests are used to directly detect the presence of an antigen, rather than the presence of the body's immune response, or antibodies

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global PCR-Based Testing Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • SouthAmerica
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Abbott
  • Bio-Rad
  • Bosch Healthcare
  • GenMark Diagnostics
  • GSK
  • Roche
  • MeMed
  • Micronics (Sony)
  • Qorvo Biotechnologies
  • Siemens Healthineers

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2021 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         PCR-Based Testing Market, ByProduct Type, Estimates and Forecast, 2017-2027 ($Million)

o    Analyzers/Instruments

o    Kits/Panels

·         PCR-Based Testing Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)

o    Diagnosis and Treatment

o    Genetic Testing

o    Cancer

o    Evolutionary Biology

o    Others

·         PCR-Based Testing Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o    Abbott

o    Bio-Rad

o    Bosch Healthcare

o    GenMark Diagnostics

o    GSK

o    Roche

o    MeMed

o    Micronics (Sony)

o    Qorvo Biotechnologies

o    Siemens Healthineers

·         PCR-Based Testing Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America PCR-Based Testing Market, By Country

o    U.S. PCR-Based Testing Market

o    Canada PCR-Based Testing Market

o    Mexico PCR-Based Testing Market

o    Europe

§  Europe PCR-Based Testing Market, By Country

·         Germany PCR-Based Testing Market

o    UK PCR-Based Testing Market

o    France PCR-Based Testing Market

o    RussiaPCR-Based Testing Market

o    Italy PCR-Based Testing Market

o    Rest of Europe PCR-Based Testing Market

o    Asia-Pacific

§  Asia-Pacific PCR-Based Testing Market, By Country

o    ChinaPCR-Based Testing Market

o    Japan PCR-Based Testing Market

o    South KoreaPCR-Based Testing Market

o    India PCR-Based Testing Market

o    Southeast AsiaPCR-Based Testing Market

o    Rest of Asia-Pacific PCR-Based Testing Market

o    South America

§  South AmericaPCR-Based Testing Market

o    Brazil PCR-Based Testing Market

o    ArgentinaPCR-Based Testing Market

o    ColumbiaPCR-Based Testing Market

o    Rest of South America PCR-Based Testing Market

o    Middle East and Africa

§  Middle East and AfricaPCR-Based Testing Market

o    Saudi ArabiaPCR-Based Testing Market

o    UAEPCR-Based Testing Market

o    EgyptPCR-Based Testing Market

o    NigeriaPCR-Based Testing Market

o    South Africa PCR-Based Testing Market

o    Rest of MEA PCR-Based Testing Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       PCR-Based Testing Market, By Product Type

5.1.     Introduction

5.2.     Global PCR-Based Testing Revenue and Market Share by Product Type (2017-2021)

5.2.1.  Global PCR-Based Testing Revenue and Revenue Share by Product Type (2017-2021)

5.3.     Analyzers/Instruments

5.3.1.  Global Analyzers/Instruments Revenue and Growth Rate (2017-2021)

5.4.     Kits/Panels

5.4.1.  Global Kits/Panels Revenue and Growth Rate (2017-2021)

6.       PCR-Based Testing Market, By Application

6.1.     Introduction

6.2.     Global PCR-Based Testing Revenue and Market Share by Application (2017-2021)

6.2.1.  Global PCR-Based Testing Revenue and Revenue Share by Application (2017-2021)

6.3.     Diagnosis and Treatment

6.3.1.  Global Diagnosis and Treatment Revenue and Growth Rate (2017-2021)

6.4.     Genetic Testing

6.4.1.  Global Genetic Testing Revenue and Growth Rate (2017-2021)

6.5.     Cancer

6.5.1.  Global Cancer Revenue and Growth Rate (2017-2021)

6.6.     Evolutionary Biology

6.6.1.  Global Evolutionary Biology Revenue and Growth Rate (2017-2021)

6.7.     Others

6.7.1.  Global Others Revenue and Growth Rate (2017-2021)

7.       PCR-Based Testing Market, By Region

7.1.     Introduction

7.2.     Global PCR-Based Testing Revenue and Market Share by Regions

7.2.1.  Global PCR-Based Testing Revenue by Regions (2017-2021)

7.3.     North America PCR-Based Testing by Countries

7.3.1.  North America PCR-Based Testing Revenue and Growth Rate (2017-2021)

7.3.2.  North America PCR-Based Testing Revenue (Million USD) by Countries (2017-2021)

7.3.3.  United States

7.3.3.1.  United States PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.4.  Canada

7.3.4.1.  Canada PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.5.  Mexico

7.3.5.1.  Mexico PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.     Europe PCR-Based Testing by Countries

7.4.1.  Europe PCR-Based Testing Revenue and Growth Rate (2017-2021)

7.4.2.  Europe PCR-Based Testing Revenue (Million USD) by Countries (2017-2021)

7.4.3.  Germany

7.4.3.1.  Germany PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.4.  France

7.4.4.1.  France PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.5.  UK

7.4.5.1.  UK PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.6.  Russia

7.4.6.1.  Russia PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.7.  Italy

7.4.7.1.  Italy PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.     Asia-Pacific PCR-Based Testing by Countries

7.5.1.  Asia-Pacific PCR-Based Testing Revenue and Growth Rate (2017-2021)

7.5.2.  Asia-Pacific PCR-Based Testing Revenue (Million USD) by Countries (2017-2021)

7.5.3.  China

7.5.3.1.  China PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.4.  Japan

7.5.4.1.  Japan PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.5.  Korea

7.5.5.1.  Korea PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.6.  India

7.5.6.1.  India PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.     South America PCR-Based Testing by Countries

7.6.1.  South America PCR-Based Testing Revenue and Growth Rate (2017-2021)

7.6.2.  South America PCR-Based Testing Revenue (Million USD) by Countries (2017-2021)

7.6.3.  Brazil

7.6.3.1.  Brazil PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.4.  Argentina

7.6.4.1.  Argentina PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.5.  Columbia

7.6.5.1.  Columbia PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.     Middle East and Africa PCR-Based Testing by Countries

7.7.1.  Middle East and Africa PCR-Based Testing Revenue and Growth Rate (2017-2021)

7.7.2.  Middle East and Africa PCR-Based Testing Revenue (Million USD) by Countries (2017-2021)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.5.  Egypt

7.7.5.1.  Egypt PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.6.  Nigeria

7.7.6.1.  Nigeria PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.7.  South Africa

7.7.7.1.  South Africa PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.8.  Turkey

7.7.8.1.  Turkey PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2021)

8.       Company Profiles

8.1.     Abbott

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Bio-Rad

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Bosch Healthcare

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     GenMark Diagnostics

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     GSK

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Roche

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     MeMed

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Micronics (Sony)

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     Qorvo Biotechnologies

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

8.10. Siemens Healthineers

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.      Financial Overview

9.       PCR-Based Testing Market Forecast (2022-2027)

9.1.     Global PCR-Based Testing Revenue (Millions USD) and Growth Rate (2022-2027)

9.2.     PCR-Based Testing Market Forecast by Regions (2022-2027)

9.2.1.  North America PCR-Based Testing Market Forecast (2022-2027)

9.2.1.1.  United States PCR-Based Testing Market Forecast (2022-2027)

9.2.1.2.  Canada PCR-Based Testing Market Forecast (2022-2027)

9.2.1.3.  Mexico PCR-Based Testing Market Forecast (2022-2027)

9.2.2.  Europe PCR-Based Testing Market Forecast (2022-2027)

9.2.2.1.  Germany PCR-Based Testing Market Forecast (2022-2027)

9.2.2.2.  France PCR-Based Testing Market Forecast (2022-2027)

9.2.2.3.  UK PCR-Based Testing Market Forecast (2022-2027)

9.2.2.4.  Russia PCR-Based Testing Market Forecast (2022-2027)

9.2.2.5.  Italy PCR-Based Testing Market Forecast (2022-2027)

9.2.2.6.  Rest of Europe PCR-Based Testing Market Forecast (2022-2027)

9.2.3.  Asia-Pacific PCR-Based Testing Market Forecast (2022-2027)

9.2.3.1.  China PCR-Based Testing Market Forecast (2022-2027)

9.2.3.2.  Japan PCR-Based Testing Market Forecast (2022-2027)

9.2.3.3.  Korea PCR-Based Testing Market Forecast (2022-2027)

9.2.3.4.  India PCR-Based Testing Market Forecast (2022-2027)

9.2.3.5.  Southeast Asia PCR-Based Testing Market Forecast (2022-2027)

9.2.3.6.  Rest of Asia-Pacific PCR-Based Testing Market Forecast (2022-2027)

9.2.4.  South America PCR-Based Testing Market Forecast (2022-2027)

9.2.4.1.  Brazil PCR-Based Testing Market Forecast (2022-2027)

9.2.4.2.  Argentina PCR-Based Testing Market Forecast (2022-2027)

9.2.4.3.  Columbia PCR-Based Testing Market Forecast (2022-2027)

9.2.4.4.  Rest of South America PCR-Based Testing Market Forecast (2022-2027)

9.2.5.  Middle East and Africa PCR-Based Testing Market Forecast (2022-2027)

9.2.5.1.  Saudi Arabia PCR-Based Testing Market Forecast (2022-2027)

9.2.5.2.  United Arab Emirates PCR-Based Testing Market Forecast (2022-2027)

9.2.5.3.  Egypt PCR-Based Testing Market Forecast (2022-2027)

9.2.5.4.  Nigeria PCR-Based Testing Market Forecast (2022-2027)

9.2.5.5.  South Africa PCR-Based Testing Market Forecast (2022-2027)

9.2.5.6.  Turkey PCR-Based Testing Market Forecast (2022-2027)

9.2.5.7.  Rest of Middle East and Africa PCR-Based Testing Market Forecast (2022-2027)

9.3.     PCR-Based Testing Market Forecast by Product Type (2022-2027)

9.3.1.  PCR-Based Testing Forecast by Product Type (2022-2027)

9.3.2.  PCR-Based Testing Market Share Forecast by Product Type (2022-2027)

9.4.     PCR-Based Testing Market Forecast by Application (2022-2027)

9.4.1.  PCR-Based Testing Forecast by Application (2022-2027)

9.4.2.  PCR-Based Testing Market Share Forecast by Application (2022-2027)


List of Tables

List of Tables and Figures:

Figure United States PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure France PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure China PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure India PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa PCR-Based Testing Revenue (Million USD) and Growth Rate (2017-2027)
Table Global PCR-Based Testing Revenue and Revenue Share by Product Type (2017-2019)
Figure Global Analyzers/Instruments Revenue and Growth Rate (2017-2019)
Figure Global Kits/Panels Revenue and Growth Rate (2017-2019)
Table Global PCR-Based Testing Revenue and Revenue Share by Application (2017-2019)
Figure Global Diagnosis and Treatment Revenue and Growth Rate (2017-2019)
Figure Global Genetic Testing Revenue and Growth Rate (2017-2019)
Figure Global Cancer Revenue and Growth Rate (2017-2019)
Figure Global Evolutionary Biology Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global PCR-Based Testing Revenue by Regions (2017-2019)
Figure North America PCR-Based Testing Growth Rate (2017-2019)
Figure North America PCR-Based Testing Revenue and Growth Rate (2017-2019)
Figure North America PCR-Based Testing by Countries (2017-2019)
Figure North America PCR-Based Testing Revenue (Million USD) by Countries (2017-2019)
Figure United States PCR-Based Testing Growth Rate (2017-2019)
Figure United States PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada PCR-Based Testing Growth Rate (2017-2019)
Figure Canada PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico PCR-Based Testing Growth Rate (2017-2019)
Figure Mexico PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe PCR-Based Testing Growth Rate (2017-2019)
Figure Europe PCR-Based Testing Revenue and Growth Rate (2017-2019)
Figure Europe PCR-Based Testing by Countries (2017-2019)
Figure Europe PCR-Based Testing Revenue (Million USD) by Countries (2017-2019)
Figure Germany PCR-Based Testing Growth Rate (2017-2019)
Figure Germany PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France PCR-Based Testing Growth Rate (2017-2019)
Figure France PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK PCR-Based Testing Growth Rate (2017-2019)
Figure UK PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia PCR-Based Testing Growth Rate (2017-2019)
Figure Russia PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy PCR-Based Testing Growth Rate (2017-2019)
Figure Italy PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe PCR-Based Testing Growth Rate (2017-2019)
Figure Rest of Europe PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific PCR-Based Testing Growth Rate (2017-2019)
Figure Asia-Pacific PCR-Based Testing Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific PCR-Based Testing by Countries (2017-2019)
Figure Asia-Pacific PCR-Based Testing Revenue (Million USD) by Countries (2017-2019)
Figure China PCR-Based Testing Growth Rate (2017-2019)
Figure China PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan PCR-Based Testing Growth Rate (2017-2019)
Figure Japan PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea PCR-Based Testing Growth Rate (2017-2019)
Figure Korea PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India PCR-Based Testing Growth Rate (2017-2019)
Figure India PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia PCR-Based Testing Growth Rate (2017-2019)
Figure Southeast Asia PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific PCR-Based Testing Growth Rate (2017-2019)
Figure Rest of Asia-Pacific PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America PCR-Based Testing Growth Rate (2017-2019)
Figure South America PCR-Based Testing Revenue and Growth Rate (2017-2019)
Figure South America PCR-Based Testing by Countries (2017-2019)
Figure South America PCR-Based Testing Revenue (Million USD) by Countries (2017-2019)
Figure Brazil PCR-Based Testing Growth Rate (2017-2019)
Figure Brazil PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina PCR-Based Testing Growth Rate (2017-2019)
Figure Argentina PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia PCR-Based Testing Growth Rate (2017-2019)
Figure Columbia PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America PCR-Based Testing Growth Rate (2017-2019)
Figure Rest of South America PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa PCR-Based Testing Growth Rate (2017-2019)
Figure Middle East and Africa PCR-Based Testing Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa PCR-Based Testing by Countries (2017-2019)
Figure Middle East and Africa PCR-Based Testing Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia PCR-Based Testing Growth Rate (2017-2019)
Figure Saudi Arabia PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates PCR-Based Testing Growth Rate (2017-2019)
Figure United Arab Emirates PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt PCR-Based Testing Growth Rate (2017-2019)
Figure Egypt PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria PCR-Based Testing Growth Rate (2017-2019)
Figure Nigeria PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa PCR-Based Testing Growth Rate (2017-2019)
Figure South Africa PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey PCR-Based Testing Growth Rate (2017-2019)
Figure Turkey PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa PCR-Based Testing Growth Rate (2017-2019)
Figure Rest of Middle East and Africa PCR-Based Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Table Abbott PCR-Based Testing Financial Overview
Table Bio-Rad PCR-Based Testing Financial Overview
Table Bosch Healthcare PCR-Based Testing Financial Overview
Table GenMark Diagnostics PCR-Based Testing Financial Overview
Table GSK PCR-Based Testing Financial Overview
Table Roche PCR-Based Testing Financial Overview
Table MeMed PCR-Based Testing Financial Overview
Table Micronics (Sony) PCR-Based Testing Financial Overview
Table Qorvo Biotechnologies PCR-Based Testing Financial Overview
Table Siemens Healthineers PCR-Based Testing Financial Overview
Figure Global PCR-Based Testing Revenue (Millions USD) and Growth Rate (2019-2027)
Table PCR-Based Testing Market Forecast by Regions (2019-2027)
Figure North America PCR-Based Testing Market Forecast (2019-2027)
Figure United States PCR-Based Testing Market Forecast (2019-2027)
Figure Canada PCR-Based Testing Market Forecast (2019-2027)
Figure Mexico PCR-Based Testing Market Forecast (2019-2027)
Figure Europe PCR-Based Testing Market Forecast (2019-2027)
Figure Germany PCR-Based Testing Market Forecast (2019-2027)
Figure France PCR-Based Testing Market Forecast (2019-2027)
Figure UK PCR-Based Testing Market Forecast (2019-2027)
Figure Russia PCR-Based Testing Market Forecast (2019-2027)
Figure Italy PCR-Based Testing Market Forecast (2019-2027)
Figure Rest of Europe PCR-Based Testing Market Forecast (2019-2027)
Figure Asia-Pacific PCR-Based Testing Market Forecast (2019-2027)
Figure China PCR-Based Testing Market Forecast (2019-2027)
Figure Japan PCR-Based Testing Market Forecast (2019-2027)
Figure Korea PCR-Based Testing Market Forecast (2019-2027)
Figure India PCR-Based Testing Market Forecast (2019-2027)
Figure Southeast Asia PCR-Based Testing Market Forecast (2019-2027)
Figure Rest of Asia-Pacific PCR-Based Testing Market Forecast (2019-2027)
Figure South America PCR-Based Testing Market Forecast (2019-2027)
Figure Brazil PCR-Based Testing Market Forecast (2019-2027)
Figure Argentina PCR-Based Testing Market Forecast (2019-2027)
Figure Columbia PCR-Based Testing Market Forecast (2019-2027)
Figure Rest of South America PCR-Based Testing Market Forecast (2019-2027)
Figure Middle East and Africa PCR-Based Testing Market Forecast (2019-2027)
Figure Saudi Arabia PCR-Based Testing Market Forecast (2019-2027)
Figure United Arab Emirates PCR-Based Testing Market Forecast (2019-2027)
Figure Egypt PCR-Based Testing Market Forecast (2019-2027)
Figure Nigeria PCR-Based Testing Market Forecast (2019-2027)
Figure South Africa PCR-Based Testing Market Forecast (2019-2027)
Figure Turkey PCR-Based Testing Market Forecast (2019-2027)
Figure Rest of Middle East and Africa PCR-Based Testing Market Forecast (2019-2027)
Figure Global PCR-Based Testing Forecast by Product Type (2019-2027)
Figure Global PCR-Based Testing Market Share Forecast by Product Type (2019-2027)
Figure Global PCR-Based Testing Forecast by Product Type (2019-2027)
Figure Global PCR-Based Testing Forecast by Application (2019-2027)
Figure Global PCR-Based Testing Market Share Forecast by Application (2019-2027)
Figure Global PCR-Based Testing Forecast by Application (2019-2027)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*